HENNEMAN JOHN B III purchased 10.0% of their position (5K shares) of ANIKA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $73.3K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/4/2026ACC: 0001193125-26-202704
Director
Since Sep 2020
+5K
Net shares
Net buyer
$73.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$14.66
Trade value
$73.32K
% of position
10.0%
5/1/2026
49.87K→54.87K
Total
Net shares
+5K
Net value
$73.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | P · Purchase | +5K | $14.66 | $73.32K | 10.0% | 49.87K | 54.87K |
| Total | +5K | $73.32K | ||||||
Derivative Transactions0
No derivative transactions reported